# Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)

> **NCT00763035** · EARLY_PHASE1 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 14 (actual)

## Conditions studied

- Coronary Artery Disease
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Angina

## Interventions

- **DRUG:** Regadenoson
- **DRUG:** Dobutamine

## Key facts

- **NCT ID:** NCT00763035
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2010-12
- **Final completion:** 2011-03
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Potential participants with COPD/asthma unwilling to participate.
- **Last updated:** 2018-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00763035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00763035, "Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00763035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*